Sung-Bae Cho
Amministratore Delegato presso CHOA PHARMACEUTICAL CO., LTD.
Patrimonio netto: 875 295 $ in data 30/04/2024
Posizioni attive di Sung-Bae Cho
Società | Posizione | Inizio | Fine |
---|---|---|---|
CHOA PHARMACEUTICAL CO., LTD. | Direttore/Membro del Consiglio | 17/10/2014 | - |
Amministratore Delegato | 17/10/2014 | - | |
Presidente | 17/10/2014 | - |
Storia della carriera di Sung-Bae Cho
Precedenti posizioni note di Sung-Bae Cho
Società | Posizione | Inizio | Fine |
---|---|---|---|
Medipharm
Medipharm Medical DistributorsDistribution Services Medipharm, founded in 2015, is a cannabis concentrate and derivative product manufacturer based in Seongnam, South Korea. The South Korean company has a good manufacturing practices certified facility with ISO standard-built clean rooms and five primary extraction lines for delivering pure and precision-dosed cannabis products. Medipharm invests in research-driven teams, state-of-the-art technology, and downstream purification methodologies to formulate, develop, process, package, and distribute cannabis extracts and advanced cannabinoid-based products to domestic and international markets. The CEO of the private company is Sung-Hwan Cho. | Corporate Officer/Principal | - | - |
Formazione di Sung-Bae Cho
Hanyang University | Undergraduate Degree |
Statistiche
Distribuzione geografica
Corea del Sud | 4 |
Posizioni
Director/Board Member | 1 |
Chief Executive Officer | 1 |
President | 1 |
Settori
Health Technology | 2 |
Consumer Services | 2 |
Distribution Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
CHOA PHARMACEUTICAL CO., LTD. | Health Technology |
Aziende private | 1 |
---|---|
Medipharm
Medipharm Medical DistributorsDistribution Services Medipharm, founded in 2015, is a cannabis concentrate and derivative product manufacturer based in Seongnam, South Korea. The South Korean company has a good manufacturing practices certified facility with ISO standard-built clean rooms and five primary extraction lines for delivering pure and precision-dosed cannabis products. Medipharm invests in research-driven teams, state-of-the-art technology, and downstream purification methodologies to formulate, develop, process, package, and distribute cannabis extracts and advanced cannabinoid-based products to domestic and international markets. The CEO of the private company is Sung-Hwan Cho. | Distribution Services |
- Borsa valori
- Insiders
- Sung-Bae Cho
- Esperienza